IPOX Indexes start 2020 with gains. IPOX 100 U.S. (ETF: FPX) unaffected by early-year weakness in U.S. small- and mid-caps. Amid higher risk (VIX: +1.74% YTD) and falling U.S. yields on increased geopolitical tensions into the week-end, the IPOX Indexes started the New Year with gains. Significant upside was recorded by the broad, large-cap centric IPOX International (ETF: FPXI) which gained to +1.46% YTD, and extending the three-year
3-year Investing with the IPOX® International ETF (FPXI)
unadjusted relative performance jump vs. the ultra-cheap benchmarks to a massive ca. +3181 bps. Specifically, the portfolio benefited from continued strength in China-linked exposure (CNI: +1.90%) which rose strongly on optimism about China central bank policy seeking to further stimulate economic growth, the positive prospects for Chinese technology stocks and strength in select Brazil-traded health care related stocks. Individual IPOX International (ETF: FPXI) Portfolio holdings to highlight include Brazil-traded managed health care services providers Hapvida Participacoes (HAPV3 BZ: +8.37%) and Notre Dame Intermedica Participacoes (GNDI3 BZ: +6.96%), as well as the slew of China-linked technology, consumer and health-care linked exposure tracked in the portfolio such as US-traded e-commerce platform operator Pinduoduo (PDD US: +8.12%), educational software maker GSX Techedu (GSX US: +7.18%), “hot pot” restaurant operator Hong Kong-traded Haidilao International (6862 HK: +5.75%) and biotech Wuxi Biologics (2269 HK: +2.99%). We also note a strong start into the New Year by Madrid-traded telecom Tower operator Cellnex Telecom (CLNX SM: +5.03%) which gained after announcing the purchase of infrastructure assets across Portugal from its joint venture including telecom Altice Europe (ATC NA: +3.17%) and investment bank Morgan Stanley (MS US: +0.16%). Profit taking across a number of portfolio holdings including Copenhagen-traded leading windfarm operator Orsted (ORSTED DC: -1.68%) capped upside towards the week-end. In the U.S., the IPOX 100 U.S. (ETF: FPX) rose to +0.32% YTD, outperforming the S&P 500 (SPX: +0.13%), Russell 2000 (RTY: -0.46%) and S&P Mid-Cap (MID: -0.36%), while lagging U.S. technology stocks (NDX: +0.70%). Here, 52/100 portfolio holdings rose on the week, with the average (median) equally-weighted firm adding +0.49% (+0.15%). Software makers ranked amongst the best performing portfolio holdings, including Coupa Software (COUP US: +9.11%) and Avalara (AVLR US: +7.66%), while IPO M&A, S&P 500 (SPX) inclusion candidate electric car maker Tesla (TSLA US: +5.90%) and IL-based French fries maker Spin-off Lamb Weston (LW US: +8.75%) extended recent gains after business updates.
|Select IPOX® Indexes Price Returns (%)||2018||2019||2020 YTD|
|IPOX® Indexes: Global/International|
|IPOX® Global (IPGL50) (USD)||-11.37||27.93||1.07|
|IPOX® International (IPXI)* (USD)||-13.41||31.37||0.97|
|IPOX® Indexes: United States|
|IPOX® 100 U.S. (IPXO)* (USD)||-8.80||29.60||0.32|
|IPOX® Indexes: Europe/Nordic|
|IPOX® 30 Europe (IXTE) (EUR)||-13.46||34.55||0.57|
|IPOX® Nordic (IPND)||-15.45||38.52||0.50|
|IPOX® 100 Europe (IPOE)* (USD)||-16.60||30.97||0.12|
|IPOX® Indexes: Asia-Pacific/China|
|IPOX® Asia-Pacific (IPTA) (USD)||-3.21||4.41||0.27|
|IPOX® China (CNI) (USD)||-22.83||26.31||1.90|
|IPOX® Japan (IPJP)** (JPY)||-13.70||7.91||0.00|
* Basis for ETFs: FPX US, FPX LN, FPXE US, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures (IPOH0). Source: Bloomberg.
IPOX ETFs 2020 YTD Returns: IPOX 100 U.S. (ETF: FPX): +0.46%, IPOX International (ETF: FPXI): +1.46%, IPOX 100 Europe (ETF: FPXE): -0.11%.
13-year Investing with the IPOX® 100 U.S. ETF (FPX)
No U.S. IPOs lined up, focus on deals across Asia-Pacific. With no IPOs expected to list in the U.S. and Europe, firms set to list across Asia-Pacific include H.K.-traded micro-caps engineering and construction services provider Kwan Yong (9998 HK) and electronic components maker Wise Ally International (9918 HK), as well as Jakarta-listed Financial Bank Amar Indonesia (AMAR IJ).
Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.